Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2017-12-02 2017-12-01
Drug Identification Number 02248261 02248261
Brand name MYLAN-GABAPENTIN MYLAN-GABAPENTIN
Common or Proper name GABAPENTIN GABAPENTIN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients GABAPENTIN GABAPENTIN
Strength(s) 400MG 400MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100BT, 500BT 100BT, 500BT
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-12-01 2017-12-01
Actual discontinuation date 2017-12-01 2017-12-01
Remaining supply date 2017-12-01 2017-12-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments